Osiris Therapeutics Inc. (OSIR)

15.75
0.30 1.90
NASDAQ : Health Technology
Prev Close 16.05
Open 16.04
Day Low/High 15.75 / 16.04
52 Wk Low/High 7.01 / 16.16
Volume 15.15K
Avg Volume 101.00K
Exchange NASDAQ
Shares Outstanding 34.53M
Market Cap 547.24M
EPS 0.20
P/E Ratio 99.06
Div & Yield N.A. (N.A)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud By Osiris Therapeutics, Inc. And Certain Officers And Directors

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud By Osiris Therapeutics, Inc. And Certain Officers And Directors

Levi & Korsinsky, LLP announces that it has commenced an investigation of Osiris Therapeutics, Inc.

Osiris Therapeutics To Attend The Brean Capital 2015 Life Sciences Summit

Osiris Therapeutics To Attend The Brean Capital 2015 Life Sciences Summit

Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine,...

Osiris Therapeutics Announces Third Quarter 2015 Financial Results

Osiris Therapeutics Announces Third Quarter 2015 Financial Results

Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced...

Osiris Therapeutics Announces A New Product: Stravix™

Osiris Therapeutics Announces A New Product: Stravix™

Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced...

Osiris Therapeutics Announces An Addition To Its Wound Care Portfolio, TruSkin™

Osiris Therapeutics Announces An Addition To Its Wound Care Portfolio, TruSkin™

Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced...

Osiris Therapeutics Announces Third Quarter 2015 Financial Results Conference Call

Osiris Therapeutics Announces Third Quarter 2015 Financial Results Conference Call

Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for third quarter ended September 30, 2015, on Friday, November 6, 2015.

'Mad Money' Lightning Round: I'm Not Abandoning Rite Aid

'Mad Money' Lightning Round: I'm Not Abandoning Rite Aid

Cramer says Osiris Therapeutics is exciting, Opko Health is a buy and you can't go wrong with PPG Industries.

Jim Cramer's 'Mad Money' Recap: Be Patient, Then Start Buying

Jim Cramer's 'Mad Money' Recap: Be Patient, Then Start Buying

Markets weren't as overheated today, Cramer says. You can buy stocks at great prices if you are patient.

Commit To Purchase Osiris Therapeutics At $16, Earn 21.1% Annualized Using Options

Commit To Purchase Osiris Therapeutics At $16, Earn 21.1% Annualized Using Options

Investors eyeing a purchase of Osiris Therapeutics Inc stock, but tentative about paying the going market price of $16.91/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2016 put at the $16 strike, which has a bid at the time of this writing of $1.20.

Osiris Announces Initiation Of A Phase III Trial For A New Investigational Drug, OTI-15-01, For The Treatment Of Chronic Diabetic Foot Wounds

Osiris Announces Initiation Of A Phase III Trial For A New Investigational Drug, OTI-15-01, For The Treatment Of Chronic Diabetic Foot Wounds

Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, today...

Osiris Therapeutics To Present At The 2015 Stem Cell Meeting On The Mesa

Osiris Therapeutics To Present At The 2015 Stem Cell Meeting On The Mesa

Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine markets,...

Osiris To Present Advanced Research On Chronic Wound Treatment Using Its Viable Cryopreserved Placental Membrane

Osiris To Present Advanced Research On Chronic Wound Treatment Using Its Viable Cryopreserved Placental Membrane

Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, will present...

Osiris Therapeutics Appoints New Chief Financial Officer And Chief Business Officer

Osiris Therapeutics Appoints New Chief Financial Officer And Chief Business Officer

Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine,...

Osiris Therapeutics Announces Special Dividend

Osiris Therapeutics Announces Special Dividend

Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine,...

Osiris Therapeutics Announces Second Quarter 2015 Financial Results

Osiris Therapeutics Announces Second Quarter 2015 Financial Results

Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced...

Trade-Ideas: Osiris Therapeutics (OSIR) Is Today's Strong And Under The Radar Stock

Trade-Ideas: Osiris Therapeutics (OSIR) Is Today's Strong And Under The Radar Stock

Trade-Ideas LLC identified Osiris Therapeutics (OSIR) as a strong and under the radar candidate

Commit To Purchase Osiris Therapeutics At $18, Earn 8.8% Annualized Using Options

Commit To Purchase Osiris Therapeutics At $18, Earn 8.8% Annualized Using Options

Investors considering a purchase of Osiris Therapeutics Inc stock, but cautious about paying the going market price of $20.96/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2016 put at the $18 strike, which has a bid at the time of this writing of 95 cents.

Osiris Therapeutics Announces Second Quarter 2015 Financial Results Conference Call

Osiris Therapeutics Announces Second Quarter 2015 Financial Results Conference Call

Osiris Therapeutics, Inc. (NASDAQ:OSIR) today announced that it will report its financial results for second quarter ended June 30, 2015, on Wednesday, August 5, 2015.

Strong And Under The Radar: Osiris Therapeutics (OSIR)

Strong And Under The Radar: Osiris Therapeutics (OSIR)

Trade-Ideas LLC identified Osiris Therapeutics (OSIR) as a strong and under the radar candidate

'Mad Money' Lightning Round: Buy Disney, Be Careful With Exelixis

'Mad Money' Lightning Round: Buy Disney, Be Careful With Exelixis

Cramer says Seagate Technology has stalled and he's sticking with Paccar.

Jim Cramer's 'Mad Money' Recap: Here's My Game Plan for Next Week

Jim Cramer's 'Mad Money' Recap: Here's My Game Plan for Next Week

It's earnings, earnings, earnings in a holiday-shortened week, and Cramer will be watching.

Osiris Evaluates The Establishment Of An International Subsidiary

Osiris Evaluates The Establishment Of An International Subsidiary

Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine,...

Don't Miss Today's Strong And Under The Radar Stock: Osiris Therapeutics (OSIR)

Don't Miss Today's Strong And Under The Radar Stock: Osiris Therapeutics (OSIR)

Trade-Ideas LLC identified Osiris Therapeutics (OSIR) as a strong and under the radar candidate

Osiris Therapeutics Announces First Quarter 2015 Financial Results

Osiris Therapeutics Announces First Quarter 2015 Financial Results

Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine,...

RSI Alert: Osiris Therapeutics (OSIR) Now Oversold

RSI Alert: Osiris Therapeutics (OSIR) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Osiris To Present Advanced Research On Chronic Wound Treatment Using Cryopreserved Placental Membranes

Osiris To Present Advanced Research On Chronic Wound Treatment Using Cryopreserved Placental Membranes

Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, will present...

Osiris Therapeutics Announces First Quarter 2015 Financial Results Conference Call

Osiris Therapeutics Announces First Quarter 2015 Financial Results Conference Call

Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for first quarter ended March 31, 2015, on Friday, May 8, 2015.

Osiris Therapeutics Announces Alla Danilkovitch, Ph.D., As Chief Scientific Officer

Osiris Therapeutics Announces Alla Danilkovitch, Ph.D., As Chief Scientific Officer

Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedic and sports medicine markets is...

Osiris Therapeutics To Present At The 3rd Annual Regen Med Investor Day

Osiris Therapeutics To Present At The 3rd Annual Regen Med Investor Day

Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedic and sports medicine markets...

Commit To Purchase Osiris Therapeutics At $15, Earn 10% Annualized Using Options

Commit To Purchase Osiris Therapeutics At $15, Earn 10% Annualized Using Options

Investors considering a purchase of Osiris Therapeutics Inc shares, but tentative about paying the going market price of $17.61/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $15 strike, which has a bid at the time of this writing of 65 cents.

TheStreet Quant Rating: B- (Buy)